Search
Selected: All

14,16.beta.-ethano-15.beta., 16(1)-cyclo-14.beta.-estra-1,3,5(10

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14,17.alpha.-etheno- and -ethanoestratrienes, processes for the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14,17.beta.-ethano-14.beta.-estratrienes and estratetraenes, pro

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14-β, 17-α-hydroxymethylandrostane derivatives...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14-.alpha., 17-.alpha.-C.sub.2 bridged norprogesterone derivativ

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14-aminosteroid derivatives, application in therapy and process

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14-deoxy-14.alpha.-cardenolides 3.beta.-thioderivatives and phar

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14.alpha., 16.alpha.-ethanoand 14.alpha., 16.alpha.-etheno-estra

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14.alpha., 17.alpha.-C.sub.2 -bridged norprogesterone derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14.alpha., 17.alpha.-ethano-16.alpha.-hydroxy-estratrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14.alpha.,17.alpha.-ethanoestratrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14.alpha.17.alpha.-(Propano-and 17.sup.2 propeno) -estratrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

14.beta.-H-, 14-and 15-En-11.beta.-aryl-4-oestrenes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

15 β-substituted steroids having selective estrogenic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

15α-substituted estradiol carboxylic acid esters as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

15,15-dialkyl-substituted derivatives of estradiol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

15,16 -Methylene-17.alpha.-pregna-4,6-diene-21-carboxylic acid s

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

16 unsaturated C17 heterocyclic steroids useful as steroid C17-2

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

16,17 acetals of pregnane derivatives and pharmaceutical composi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

16,17-acetalsubstituted androstane-17.beta.-carboxylic acid este

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.